BIOEQUIVALENCE
Clinical trials for BIOEQUIVALENCE explained in plain language.
Never miss a new study
Get alerted when new BIOEQUIVALENCE trials appear
Sign up with your email to follow new studies for BIOEQUIVALENCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New liquid form of PKU drug tested for equivalence
Knowledge-focused CompletedThis study checks if a new liquid form of sapropterin (RLF-OD032) works the same as the approved powder (Kuvan) in 42 healthy adults. Participants receive a single dose of each version under fed conditions, and blood samples are taken to compare drug levels. The goal is to see if…
Matched conditions: BIOEQUIVALENCE
Phase: PHASE1 • Sponsor: APR Applied Pharma Research s.a. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Mini advil tablet tested for effectiveness and food effects
Knowledge-focused CompletedThis completed study tested whether a new, smaller Advil tablet (Mini) works the same as the regular Advil tablet. Fifty healthy adults took single doses of both tablets under fasting conditions, and also took the Mini tablet with food to see how meals affect its absorption. The …
Matched conditions: BIOEQUIVALENCE
Phase: PHASE1 • Sponsor: HALEON • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Seizure drug showdown: granules vs tablets in healthy volunteers
Knowledge-focused CompletedThis study tested whether a new granule form of the seizure medicine levetiracetam works the same as the standard tablet form. Twenty healthy adults took both versions under fasting conditions. The goal was to check if the body absorbs the medicine similarly, which helps ensure t…
Matched conditions: BIOEQUIVALENCE
Phase: PHASE1 • Sponsor: Desitin Arzneimittel GmbH • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Healthy volunteers test two forms of experimental drug
Knowledge-focused CompletedThis early-stage study compared two versions (tablet vs capsule) of the experimental drug KBP-5074 in 20 healthy adults. The goal was to see how the body absorbs each form and whether they work similarly. Results will help choose the right dose for future studies.
Matched conditions: BIOEQUIVALENCE
Phase: PHASE1 • Sponsor: KBP Biosciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC